You have 9 free searches left this month | for more free features.

Immunoreconstitution

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Poor Thymic Function, Immunodeficiency, Athymia Trial (biological, procedure, drug)

Approved for marketing
  • Poor Thymic Function
  • +5 more
  • Cultured Thymus Tissue
  • +2 more
  • (no location specified)
Mar 23, 2022

Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
  • (no location specified)
Aug 23, 2022

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)

Recruiting
  • Hematopoietic Organs; Disorder
  • Total lymphoid irradiation
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Oct 4, 2023

DiGeorge Anomaly Trial (Serum Free Thymus Transplantation with Immunosuppression, Serum Free Thymus Transplantation without

Terminated
  • DiGeorge Anomaly
  • Serum Free Thymus Transplantation with Immunosuppression
  • Serum Free Thymus Transplantation without immunosuppression
  • (no location specified)
Mar 21, 2022

DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge Anomaly Trial in Durham (Thymus Tissue for Transplantation)

Completed
  • DiGeorge Syndrome
  • +3 more
  • Thymus Tissue for Transplantation
  • Durham, North Carolina
    Duke University Medical Center
Mar 23, 2022

Complete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly Trial in Durham (biological, procedure, drug)

Approved for marketing
  • Complete DiGeorge Anomaly
  • +3 more
  • Cultured Thymus Tissue
  • +6 more
  • Durham, North Carolina
    John W. Sleasman
Mar 21, 2022

DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,

Completed
  • DiGeorge Anomaly
  • +4 more
  • Cultured Thymus Tissue for Implantation (CTTI)
  • +8 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 23, 2022

Acute Leukemia (Category) Trial in Worldwide (HSV-Tk, T-cell depleted or T-cell replete strategies)

Terminated
  • Acute Leukemia (Category)
  • HSV-Tk
  • T-cell depleted or T-cell replete strategies
  • Chicago, Illinois
  • +35 more
Jun 1, 2021

Cytomegalovirus Infection, Adenovirus Infection Trial in Vienna (virus-specific T-Cells)

Withdrawn
  • Cytomegalovirus Infection
  • Adenovirus Infection
  • virus-specific T-Cells
  • Vienna, Austria
    St. Anna Children's Hospital
May 7, 2019

Malignant and Non-malignant High Risk Diseases Trial in Frankfurt am Main (Hematopoietic stem cell product from haploidentical

Terminated
  • Malignant and Non-malignant High Risk Diseases
  • Hematopoietic stem cell product from haploidentical or unrelated donor CD3/CD19 depleted with CliniMACS
  • Frankfurt am Main, Hessen, Germany
    University Hospital Frankfurt, Dept. for Children and Adolescent
Aug 13, 2018

Chinese Network of Pediatric Antiretroviral Therapy

Completed
  • Acquired Immunodeficiency Syndrome
    • Beijing, China
      National Center for AIDS/STD Control and Prevention, China Cente
    Mar 28, 2018

    Non-Hodgkin Lymphoma Trial in Germany (Radioimmunotherapy, allogeneic hematopoietic cell transplantation)

    Completed
    • Non-Hodgkin Lymphoma
    • Berlin, Germany
    • +10 more
    May 28, 2014

    HIV Trial in Cambodia, Thailand (Abacavir, Efavirenz, Lamivudine)

    Completed
    • HIV Infections
    • Phnom Penh, Cambodia
    • +8 more
    Dec 2, 2013

    Leukemia Trial in New York (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • anti-thymocyte globulin
    • +8 more
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 24, 2013

    Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency Trial in Minneapolis

    Terminated
    • Immunologic Deficiency Syndromes
    • +13 more
    • anti-thymocyte globulin
    • +8 more
    • Minneapolis, Minnesota
      Fairview University Medical Center
    Oct 14, 2009

    HIV Infection Trial run by the NCI (Ritonavir, Nevirapine, Stavudine)

    Completed
    • HIV Infection
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Mar 3, 2008

    HIV-Infected Children Receiving Protease Inhibitor and Reverse

    Completed
    • HIV Infection
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Mar 3, 2008

      HIV Trial run by the NCI (Eye exam, Oral exam, CT scan)

      Completed
      • HIV Infections
      • Eye exam
      • +5 more
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Mar 3, 2008